In this study, we confirmed that GADD45A reduced the expression of β-catenin and MMP-9 in IDH1R132H glioblastoma cells, providing a deeper insight into how β-catenin is regulated in these tumors [10]. This evidence concerns the gene MMP9 and glioblastoma.